© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Role of adenosine in delayed preconditioning of myocardium
Department of Basic Biological Sciences, The Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
* Corresponding author. Tel.: +44-20-7468-5000; fax: +44-20-7388-1027 gfbaxter{at}rvc.ac.uk
Myocardial protection conferred by ischemic preconditioning occurs in a bimodal time course. The early cardioprotection wanes rapidly and is succeeded by a delayed phase of protection reducing infarct development, myocardial stunning and arrhythmias. This ‘second window’ of preconditioning may be evident for up to 72 h. The current mechanistic paradigm for delayed preconditioning against infarction invokes roles for several freely-diffusible molecules, generated during the preconditioning period, that act in autocrine and/or paracrine fashion as triggers of cellular adaptation. These include adenosine, nitric oxide, reactive oxygen species and bradykinin. A role for adenosine receptor activation as a proximal molecular mechanism leading to delayed preconditioning against infarction was established in 1994. Pharmacological adenosine receptor blockade during preconditioning abolishes the acquisition of delayed protection, while transient adenosine A1 or A3 receptor activation fully recapitulates protection against infarction (but not against stunning or arrhythmias) 24 h later. Although nitric oxide is a co-trigger of delayed preconditioning, A1 agonist-induced delayed protection is independent of nitric oxide production. Adenosine receptor activation causes the activation of a complex protein kinase signalling cascade and, putatively, the subsequent activation of gene transcription. The induction or post-translational regulation of several proteins is associated with A1 agonist-induced delayed protection. These include the mitochondrial manganese-conjugated superoxide dismutase, and the 27-kDa heat shock protein. Opening of KATP channels during the index ischaemic event is an obligatory downstream event mediating A1 and A3 agonist induced delayed protection. However, the mechanism of sub-acute regulation of KATP channels following adenosine receptor activation is unknown. Evidence for induction of inducible nitric oxide synthase as a distal mechanism of A1 agonist-induced delayed protection is equivocal.
KEYWORDS CCPA, 2-Chloro-N6-cyclopentyladenosine; CGS21680, 2-[4-(2-Carboxyethyl)phenyl-ethylamino]-5'-N-ethylcarboxamidoadenosine; COX-2, Cyclo-oxygenase-2; HSP27, 27-kDa Heat shock protein; HSP72, 72-kDa Heat shock protein; IBMECA, N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide; eNOS, Endothelial nitric oxide synthase; GR79236, N-[(1S, trans)-2-Hydroxycyclopentyl]adenosine; 5-HD, Sodium 5-hydoxydecanoate; iNOS, Inducible nitric oxide synthase; KATP, ATP-Sensitive potassium channel; L-NAME, Nitro-L-argine methyl ester; MAP, Kinase mitogen activated protein kinase; MAPKAPK-2, MAP Kinase-activated protein kinase-2; Mn–SOD, Manganese-conjugated superoxide dismutase; NO, Nitric oxide; PD115199, 1,3-[Dipropyl-8-N-(2-diethylamino)ethyl]-N-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo); benzenesulph-onamidexanthine PKC protein kinase C; 8-SPT, 8-(p-Sulphophenyl)theophylline; TTC, Triphenyltetrazolium chloride
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Y. Saadjian, V. Gerolami, R. Giorgi, L. Mercier, J.-L. Berge-Lefranc, F. Paganelli, Z. Ibrahim, Y. By, J. L. Gueant, S. Levy, et al. Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism Eur. Heart J., June 2, 2009; 30(12): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Eckle, M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig A2B adenosine receptor dampens hypoxia-induced vascular leak Blood, February 15, 2008; 111(4): 2024 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Joo, M. Kim, P. Horst, J. Kim, V. D. D'Agati, C. W. Emala Sr., and H. T. Lee Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1847 - F1857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Loffler, J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig Physiological Roles of Vascular Nucleoside Transporters Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1004 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Lankford, J.-N. Yang, R. Rose'Meyer, B. A. French, G. P. Matherne, B. B. Fredholm, and Z. Yang Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1469 - H1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bright and D. Mochly-Rosen The Role of Protein Kinase C in Cerebral Ischemic and Reperfusion Injury Stroke, December 1, 2005; 36(12): 2781 - 2790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Canyon and G. P. Dobson Pretreatment with an adenosine A1 receptor agonist and lidocaine: A possible alternative to myocardial ischemic preconditioning J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sharony, I. Frolkis, D. Froylich, S. M. Wildhirt, I. Shapira, B. Reichart, N. Nesher, and G. Uretzky Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Thompson, H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan Crucial Role for Ecto-5'-Nucleotidase (CD73) in Vascular Leakage during Hypoxia J. Exp. Med., December 6, 2004; 200(11): 1395 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kristo, Y. Yoshimura, B. J. Keith, R. M. Stevens, S. A. Jahania, R. M. Mentzer Jr., and R. D. Lasley Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2746 - H2753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E Mangoni and S. Barrere-Lemaire Adenosine receptors, heart rate, and cardioprotection Cardiovasc Res, June 1, 2004; 62(3): 447 - 449. [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz, M. Kelm, and G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 402 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Angelo, E. Duplan, N. Boyer, P. Vigne, and C. Frelin Hypoxia Up-regulates Prolyl Hydroxylase Activity: A FEEDBACK MECHANSIM THAT LIMITS HIF-1 RESPONSES DURING REOXYGENATION J. Biol. Chem., October 3, 2003; 278(40): 38183 - 38187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Peart and G. J. Gross Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H81 - H89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Regan, M. Broad, A. M. Byford, A. R. Lankford, R. J. Cerniway, M. W. Mayo, and G. P. Matherne A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H859 - H866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M Yellon and J. M Downey Spotlight on preconditioning Cardiovasc Res, August 15, 2002; 55(3): 425 - 428. [Full Text] [PDF]
|
|